|
Autologous Cell Therapy for Diabetes Mellitus
This technology is the development of novel insulin-producing cells by using preadipocytes from the same animal, which can be autografted. Because the cells are isolated from a small amount of fat from the same organism, the chance of immune rejection is nonexistent. These preadipocytes undergo terminal differentiation into mature adipocytes, which...
Published: 4/3/2023
|
Inventor(s): Ravi Goyal, Sean Limesand
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Diabetes, Metabolism, Endocrinology & Obesity
|
